{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:31:51Z","timestamp":1785861111455,"version":"3.56.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1097\/01.bor.0000240370.47336.ae","type":"journal-article","created":{"date-parts":[[2006,8,8]],"date-time":"2006-08-08T04:10:52Z","timestamp":1155010252000},"page":"548-555","source":"Crossref","is-referenced-by-count":19,"title":["Complement dysfunction in hemolytic uremic syndrome"],"prefix":"10.1097","volume":"18","author":[{"given":"Peter F","family":"Zipfel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Skerka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20-20210128","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1681\/ASN.2004100861","article-title":"Hemolytic uremic syndrome","volume":"16","author":"Noris","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R3-20-20210128","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.4049\/jimmunol.176.3.1305","article-title":"The central role of the alternative complement pathway in human disease","volume":"176","author":"Thurman","year":"2006","journal-title":"J Immunol"},{"key":"R4-20-20210128","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1196\/annals.1352.032","article-title":"Hemolytic uremic syndrome: an example of insufficient complement regulation on self-tissue","volume":"1056","author":"Atkinson","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"R5-20-20210128","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/01.mop.0000152997.66070.e9","article-title":"Hemolytic uremic syndrome: pathogenesis, treatment, and outcome","volume":"17","author":"Siegler","year":"2005","journal-title":"Curr Opin Pediatr"},{"key":"R6-20-20210128","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.molimm.2005.06.015","article-title":"Complement and diseases: defective alternative pathway control results in kidney and eye diseases","volume":"43","author":"Zipfel","year":"2006","journal-title":"Mol Immunol"},{"key":"R7-20-20210128","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/01.mnh.0000165887.75501.24","article-title":"Complement and glomerulonephritis: new insights","volume":"14","author":"Thurnberg","year":"2005","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R8-20-20210128","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1055\/s-2006-939770","article-title":"The role of defective complement control in haemolytic uraemic syndrome","volume":"32","author":"Zipfel","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"R9-20-20210128","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1523-1755.1998.00824.x","article-title":"Genetic studies into inherited and sporadic hemolytic uremic syndrome","volume":"53","author":"Warwicker","year":"1998","journal-title":"Kidney Int"},{"key":"R10-20-20210128","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1086\/318201","article-title":"Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome","volume":"68","author":"Perez-Caballero","year":"2001","journal-title":"Am J Hum Genet"},{"key":"R11-20-20210128","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1681\/ASN.V122297","article-title":"The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20","volume":"12","author":"Caprioli","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R12-20-20210128","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1136\/jmg.40.9.676","article-title":"Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries","volume":"40","author":"Neumann","year":"2003","journal-title":"J Med Genet"},{"key":"R13-20-20210128","doi-asserted-by":"crossref","first-page":"12966","DOI":"10.1073\/pnas.2135497100","article-title":"Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome","volume":"100","author":"Richards","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"R14-20-20210128","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/S0140-6736(03)14742-3","article-title":"Familial haemolytic uraemic syndrome and an MCP mutation","volume":"362","author":"Noris","year":"2003","journal-title":"Lancet"},{"key":"R15-20-20210128","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.molimm.2005.11.008","article-title":"Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in large, multiple affected pedigree","volume":"43","author":"Esparza-Gordillo","year":"2006","journal-title":"Mol Immunol"},{"key":"R16-20-20210128","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1136\/jmg.2004.019083","article-title":"Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome","volume":"41","author":"Fremeaux-Bacchi","year":"2004","journal-title":"J Med Genet"},{"key":"R17-20-20210128","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1681\/ASN.2005010103","article-title":"Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome","volume":"16","author":"Kavanagh","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R18-20-20210128","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/sj.ki.5000155","article-title":"Phenotypic expression of factor H mutations inpatients with atypical haemolytic uremic syndrome","volume":"69","author":"Vaziri-Sani","year":"2006","journal-title":"Kidney Int"},{"key":"R19-20-20210128","doi-asserted-by":"crossref","first-page":"16879","DOI":"10.1073\/pnas.0406678101","article-title":"Activation of the complement system generates antibacterial peptides","volume":"101","author":"Nordahl","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"R20-20-20210128","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-2001-15248","article-title":"Complement factor H: physiology and pathophysiology","volume":"27","author":"Zipfel","year":"2001","journal-title":"Semin Thromb Hemost"},{"key":"R21-20-20210128","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molimm.2004.02.005","article-title":"The human complement factor H: functional roles, genetic variations and disease associations","volume":"41","author":"Rodriguez de Cordoba","year":"2004","journal-title":"Mol Immunol"},{"key":"R22-20-20210128","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1172\/JCI16651","article-title":"Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome","volume":"111","author":"Manuelian","year":"2003","journal-title":"J Clin Invest"},{"key":"R23-20-20210128","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0002-9440(10)61205-9","article-title":"Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site","volume":"167","author":"Jokiranta","year":"2005","journal-title":"Am J Pathol"},{"key":"R24-20-20210128","first-page":"85","article-title":"Role of complement and factor H in haemolytic uraemic syndrome","author":"Skerka","year":"2006"},{"key":"R25-20-20210128","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/humu.20268","article-title":"An interactive web database of factor H associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations","volume":"27","author":"Saunders","year":"2006","journal-title":"Hum Mutat"},{"key":"R26-20-20210128","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1681\/ASN.2005080868","article-title":"Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions","volume":"17","author":"Jozsi","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R27-20-20210128","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0065-2776(08)60868-8","article-title":"Control of the complement system","volume":"61","author":"Liszewski","year":"1996","journal-title":"Adv Immunol"},{"key":"R28-20-20210128","doi-asserted-by":"crossref","DOI":"10.1016\/B978-012733360-1\/50016-6","article-title":"Factor I","author":"Morley","year":"2000"},{"key":"R29-20-20210128","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.molimm.2005.06.041","article-title":"Does complement factor B have a role in the pathogenesis of atypical HUS?","volume":"43","author":"Kavanagh","year":"2006","journal-title":"Mol Immunol"},{"key":"R30-20-20210128","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/hmg\/ddi066","article-title":"Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32","volume":"14","author":"Esparza-Gordillo","year":"2005","journal-title":"Hum Mol Genet"},{"key":"R31-20-20210128","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/jmg.2005.030783","article-title":"The development of atypical haemolytic\u2013uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts","volume":"42","author":"Fremeaux-Bacchi","year":"2005","journal-title":"J Med Genet"},{"key":"R32-20-20210128","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1093\/hmg\/ddg363","article-title":"Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease","volume":"12","author":"Caprioli","year":"2003","journal-title":"Hum Mol Genet"},{"key":"R33-20-20210128","first-page":"292","article-title":"De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome","volume":"27","author":"Heinen","year":"2006","journal-title":"Hum Genetics"},{"key":"R34-20-20210128","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/S0002-9440(10)64481-1","article-title":"The molecular basis for hereditary porcine membranoproliferative glomerulonephritis type II: point mutations in the factor H coding sequence block protein secretion","volume":"161","author":"Hegasy","year":"2002","journal-title":"Am J Pathol"},{"key":"R35-20-20210128","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1681\/ASN.2004050380","article-title":"Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome","volume":"16","author":"Dragon-Durey","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R36-20-20210128","first-page":"85","article-title":"Complement defects in children which result in kidney diseases: diagnosis and therapy","author":"Licht","year":"2006"},{"key":"R37-20-20210128","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s00467-004-1526-9","article-title":"Challenges in the management of infantile factor H associated hemolytic uremic syndrome","volume":"19","author":"Filler","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"R38-20-20210128","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/j.ajkd.2004.10.018","article-title":"Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15","volume":"45","author":"Licht","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R40-20-20210128","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1055\/s-2006-939771","article-title":"Membrane cofactor protein and factor I: mutations and transplantation","volume":"32","author":"Kavanagh","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"R41-20-20210128","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1600-6143.2005.00783.x","article-title":"Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor H gene mutation","volume":"5","author":"Remuzzi","year":"2005","journal-title":"Am J Transplant"},{"key":"R42-20-20210128","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s00467-003-1371-2","article-title":"Attempted treatment of factor H deficiency by liver transplantation","volume":"19","author":"Cheong","year":"2004","journal-title":"Pediatr Nephrol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00005053-200608000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:38:59Z","timestamp":1785857939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002281-200609000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.bor.0000240370.47336.ae","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}